Please login to the form below

Not currently logged in
Email:
Password:

Former Roche development head joins Asana advisory board

Dr Kapil Dhingra also brings experience from Lilly

Asana BioSciences Dr Kapil DhingraAsana BioSciences has appointed former head of Roche oncology clinical development Dr Kapil Dhingra to its oncology scientific advisory board.

Dr Dhingra served at Roche from 1999 to 2008, most recently as vice president, head of the Swiss pharma company's oncology disease biology leadership team and head of oncology clinical development.

Prior to that he worked at Lilly as a clinical research physician having previously served at the faculty of M.D. Anderson Cancer Center in Houston, Texas, where he pursued laboratory and clinical cancer research.

Dr Sandeep Gupta, founder, president and CEO of New Jersey-based Asana Biosciences, said: “We welcome Dr. Dhingra to our oncology scientific advisory board. His expertise, proven track record and strategic insights will be great assets to Asana.

I look forward to working closely with him and other SAB members in advancing our robust and differentiated oncology pipeline further into clinical development.”

The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.

11th January 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics